Source: Advances in Rheumatology. Unidades: FMRP, FM
Subjects: ARTRITE REUMATOIDE, ALOPECIA, DOENÇAS AUTOIMUNES, INIBIDORES DE ENZIMAS
ABNT
BONFIGLIOLI, Karina Rossi et al. Recommendations of the Brazilian Society of Rheumatology for the use of JAK inhibitors in the management of rheumatoid arthritis. Advances in Rheumatology, v. 61, p. 1-13, 2021Tradução . . Disponível em: https://doi.org/10.1186/s42358-021-00228-x. Acesso em: 09 out. 2025.APA
Bonfiglioli, K. R., Mota, L. M. H. da, Ribeiro, A. C. de M., Kakehasi, A. M., Laurindo, I. M. M., Giorgi, R. D. N., et al. (2021). Recommendations of the Brazilian Society of Rheumatology for the use of JAK inhibitors in the management of rheumatoid arthritis. Advances in Rheumatology, 61, 1-13. doi:10.1186/s42358-021-00228-xNLM
Bonfiglioli KR, Mota LMH da, Ribeiro AC de M, Kakehasi AM, Laurindo IMM, Giorgi RDN, Duarte ALBP, Reis APMG, Souza MPGU e S de, Brenol CV, Pinheiro G da RC, Albuquerque CP de, Castro CH de M, Pinto GLB, Verztman JF, Muniz LF, Bertolo MB, Pinto MR da C, Louzada Júnior P, Cruz VA, Pereira IA, Freitas MVC de, Cruz BA, Paiva E, Monticielo O, Provenza JR, Xavier RM. Recommendations of the Brazilian Society of Rheumatology for the use of JAK inhibitors in the management of rheumatoid arthritis [Internet]. Advances in Rheumatology. 2021 ; 61 1-13.[citado 2025 out. 09 ] Available from: https://doi.org/10.1186/s42358-021-00228-xVancouver
Bonfiglioli KR, Mota LMH da, Ribeiro AC de M, Kakehasi AM, Laurindo IMM, Giorgi RDN, Duarte ALBP, Reis APMG, Souza MPGU e S de, Brenol CV, Pinheiro G da RC, Albuquerque CP de, Castro CH de M, Pinto GLB, Verztman JF, Muniz LF, Bertolo MB, Pinto MR da C, Louzada Júnior P, Cruz VA, Pereira IA, Freitas MVC de, Cruz BA, Paiva E, Monticielo O, Provenza JR, Xavier RM. Recommendations of the Brazilian Society of Rheumatology for the use of JAK inhibitors in the management of rheumatoid arthritis [Internet]. Advances in Rheumatology. 2021 ; 61 1-13.[citado 2025 out. 09 ] Available from: https://doi.org/10.1186/s42358-021-00228-x